Make America healthy again – How new regulations require strategic communication

May 15, 2025

OPRG Healthcare team is a dedicated resource team with a combined knowledge of over 50 years in the pharmaceutical industry and healthcare sector. They share how the changing operating landscape calls for planned communications and careful consideration in this rapidly changing industry.

The pharmaceutical industry and healthcare sector are operating in a dynamic landscape,  due to the rapidly changing international political reality we are currently facing. Economic pressures and new regulations, particularly from the United States, are shaping the way forward.

In this environment, effective communication is not a luxury but a necessity. Transparency, timely information sharing, and a well-prepared crisis response make the difference between maintaining trust and losing legitimacy. It is essential that these communication priorities are recognized and strategically addressed to safeguard the future of health and well-being. Now more than ever, as U.S. policy changes and announcements like “Lowering drug prices by once again putting Americans first”, put global access to medications under pressure, strategic communication is critical to strengthening both competitive positioning and public support.

Why communication makes the difference

  1. Transparency builds trust
    In times of uncertainty, openness is essential. Clear communication about how regulations and levies affect the pricing and availability of medicines helps build trust among patients, healthcare providers, and policymakers.

  1. Information dissemination prevents misunderstandings
    New guidelines? Changes in availability? Only through proactive communication can healthcare professionals stay well-informed and patients avoid unnecessary surprises.

  1. Crisis communication as a safety net
    In acute risk situations, such as shortages caused by trade barriers, speed is critical. Companies with a well-thought-out crisis plan can respond more effectively to concerns from the media, politicians, and the public.

  1. Strategic positioning in the policy arena
    A clear message and visible presence in public debates and among policymakers strengthen the position of pharmaceutical companies and healthcare organizations as serious and responsible partners in dialogue. This enables them to contribute proactively to solutions rather than having to defend themselves reactively.

Working together for health
“As a global partner of OPRG Health, we support pharmaceutical companies and other healthcare organizations in strategically addressing these and other communication challenges. A well-thought-out and integrated public affairs and public relations approach is always advisable, but especially now, as the playing field is changing so drastically,” says Daniëlle Friskes, Business Communication Director | Healthcare specialist at Omnicom PR/PA Group Netherlands.

“Whether it’s policy advocacy, stakeholder management, or crisis communication—we are here to support pharmaceutical companies and other players in the healthcare sector, such as medical device suppliers. Because only together can we work toward accessible and affordable care.”

Talk to us about how we can help you guide your change for growth.